SCHEMBL1437865

SCHEMBL1437865

CCCCOc1ccc(COc2ccc(C3CN(CCC(=O)OC(C)(C)C)CCO3)c(C)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 2/20 0.41
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
PPARG P37231 1/20 0.41
THRB P10828 4/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
THRA P10827 1/20 0.39
GRIN1 Q05586 2/20 0.38
GRIN2B Q13224 2/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
DRD3 P35462 2/20 0.38
KDM2B Q8NHM5 1/20 0.38
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1439048 0.94 HRH3 (0.41) PSEN1PTGESALOX5PPARGTHRB
SCHEMBL1438025 0.92 EGFR (0.44) ALDH1A1GRIN1GRIN2BKDM2B
SCHEMBL1438485 0.92 NPC1 (0.39) GRIN1GRIN2BHDAC8DRD3KDM2B
SCHEMBL1438183 0.91 DRD4 (0.40) ALDH1A1LMNAMAPTKMT2AGRIN1
SCHEMBL1438140 0.90 GRIN1 (0.45) GRIN1GRIN2BHDAC8NPC1GAA
SCHEMBL1439133 0.90 DRD4 (0.40) KMT2ADRD3KDM2BNPC1GAA
SCHEMBL1438157 0.90 GRIN1 (0.41) LMNAKMT2AGRIN1GRIN2BNPC1
SCHEMBL1438059 0.90 MAOB (0.39) ALDH1A1LMNAKMT2AGRIN1GRIN2B
SCHEMBL1438554 0.90 THRB (0.43) PSEN1PTGESALOX5PPARGTHRB
SCHEMBL1437972 0.90 S1PR1 (0.45) ALDH1A1GRIN1GRIN2BKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273017-B2 (Thio)morpholine derivatives as S1P modulators ABBVIE BAHAMAS LIMITED (BS) 2016-03-01 US disclosed
US-20150239857-A1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE BAHAMAS LIMITED (BS) 2015-08-27 US disclosed
US-9045441-B2 (Thio)morpholine derivatives as S1P modulators ABBVIE BAHAMAS LIMITED (BS) 2015-06-02 US disclosed
EP-2473490-B1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE BAHAMAS LTD (BS) 2014-02-26 EP disclosed
US-20120220552-A1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBVIE BAHAMAS LIMITED (BS) 2012-08-30 US disclosed
EP-2473490-A1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS Abbott Healthcare Products B.V. (NL) 2012-07-11 EP disclosed
WO-2011023795-A1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS ABBOTT HEALTHCARE PRODUCTS B.V. (NL) 2011-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239857-A1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS S1PR3, S1PR1, S1PR2 PSEN1 1475/4885PTGES 1189/4885ALOX5 1172/4885
US-20120220552-A1 (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS S1PR3, S1PR1, S1PR2 PSEN1 1836/4885PTGES 1426/4885ALOX5 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.